Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study

Abstract Objective To elucidate the potential benefits of combining radiotherapy and epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) for individuals with Stage IV lung adenocarcinoma (LUAD) harboring either exon 19 deletion (19‐Del) or exon 21 L858R mutation (21‐L858R). Metho...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Shuai Liang, Hanyu Wang, Yingyun Zhang, Haixia Tian, Chengming Li, Dong Hua
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2024-04-01
סדרה:	Cancer Medicine
נושאים:	epidermal growth factor receptor‐tyrosine kinase inhibitor exon 19 deletion exon 21 L858R mutation radiotherapy Stage IV lung adenocarcinoma
גישה מקוונת:	https://doi.org/10.1002/cam4.7208
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!